Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07302815 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Primary completion date changed from estimate of Jul 10, 2026 to Aug 20, 2026 · Eligibility criteria expanded, about 10 words · Secondary endpoints: details revised at 2 of 5 entries · 2 more Show 5 more changesShow less
    • Primary completion date changed from estimate of Jul 10, 2026 to Aug 20, 2026
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 2 of 5 entries
    • Study description revised
    • Publications: details revised at 9 of 9 entries
  2. Trial status: Not Yet Recruiting to Active, Not Recruitingv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This prospective randomized controlled study will be conducted to evaluate the effect of preoperative single, micro-dose of dexmedetomidine (0.3μg/kg) on the incidence and severity of EA in adults undergoing Septoplasty surgeries
Trial Details
NCT Number NCT07302815
Lead Sponsor Tanta University
Conditions Emergence Agitation
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov